Charles River Laboratories | CRL - Current Assets



Charles River Laboratories reported $1.47B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Agilent USD 4.25B 45M Jul/2025
Align Technology USD 2.45B 46.03M Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
Bruker USD 2.16B 51.2M Jun/2025
Cardinal Health USD 36.37B 1.78B Jun/2025
Charles River Laboratories USD 1.47B 36.5M Jun/2025
Cigna USD 44.72B 1.17B Jun/2025
CVS Health USD 75.65B 2.46B Jun/2025
Danaher USD 11B 1.47B Jun/2025
Dentsply International USD 1.97B 12M Jun/2025
Elevance Health 63.32B 2.2B Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Humana USD 34.42B 4.61B Mar/2025
Illumina USD 2.64B 32M Jun/2025
Incyte USD 3.64B 411.91M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Laboratory Of America USD 4.09B 297.5M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
McKesson USD 56.8B 1.4B Jun/2025
Merck EUR 12.2B 216M Jun/2025
Mettler Toledo International USD 1.24B 79.67M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Quest Diagnostics USD 2.2B 123M Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
United Therapeutics USD 3.83B 112.9M Jun/2025
UnitedHealth 96.29B 10.51B Mar/2025
Waters USD 1.78B 42.24M Jun/2025
West Pharmaceutical Services USD 1.68B 223.4M Jun/2025